|
1
|
Das V, Kalita J and Pal M: Predictive and
prognostic biomarkers in colorectal cancer: A systematic review of
recent advances and challenges. Biomed Pharmacother. 87:8–19. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY,
Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al:
APC-activated long noncoding RNA inhibits colorectal carcinoma
pathogenesis through reduction of exosome production. J Clin
Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dy GK, Hobday TJ, Nelson G, Windschitl HE,
O'Connell MJ, Alberts SR, Goldberg RM, Nikcevich DA and Sargent DJ:
Long-term survivors of metastatic colorectal cancer treated with
systemic chemotherapy alone: A North Central Cancer Treatment Group
review of 3811 patients, N0144. Clin Colorectal Cancer. 8:88–93.
2009. View Article : Google Scholar
|
|
4
|
Skarkova V, Kralova V, Vitovcova B and
Rudolf E: Selected aspects of chemoresistance mechanisms in
colorectal carcinoma-a focus on epithelial-to-mesenchymal
transition, autophagy, and apoptosis. Cells. 8:2342019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SD, Yu D, Lee DY, Shin HS, Jo JH and
Lee YC: Upregulated microRNA-193a-3p is responsible for cisplatin
resistance in CD44(+) gastric cancer cells. Cancer Sci.
110:662–673. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding HX, Lv Z, Yuan Y and Xu Q: miRNA
polymorphisms and cancer prognosis: A systematic review and
meta-analysis. Front Oncol. 8:5962018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodríguez-Martínez A, de Miguel-Pérez D,
Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J,
Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, et
al: Exosomal miRNA profile as complementary tool in the diagnostic
and prediction of treatment response in localized breast cancer
under neoadjuvant chemotherapy. Breast Cancer Res. 21:212019.
View Article : Google Scholar
|
|
9
|
Vychytilova-Faltejskova P and Slaby O:
MicroRNA-215: From biology to theranostic applications. Mol Aspects
Med. 70:72–89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang R, Sun Y, Yu W, Yan Y, Qiao M, Jiang
R, Guan W and Wang L: Downregulation of miRNA-214 in
cancer-associated fibroblasts contributes to migration and invasion
of gastric cancer cells through targeting FGF9 and inducing EMT. J
Exp Clin Cancer Res. 38:202019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hou GL, Xu WF, Jin YB, Wu J, Pan Y and
Zhou F: miRNA-217 accelerates the proliferation and migration of
bladder cancer via inhibiting KMT2D. Biochem Biophys Res Commun.
519:747–753. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu AN, Qu HJ, Gong WJ, Xiang JY, Yang MM
and Zhang W: LncRNA AWPPH and miRNA-21 regulates cancer cell
proliferation and chemosensitivity in triple-negative breast cancer
by interacting with each other. J Cell Biochem. 120:14860–14866.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shivapurkar N, Weiner LM, Marshall JL,
Madhavan S, Deslattes Mays A, Juhl H and Wellstein A: Recurrence of
early stage colon cancer predicted by expression pattern of
circulating microRNAs. PLoS One. 9:e846862014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allen B, Schneider A, Victoria B, Nunez
Lopez YO, Muller M, Szewczyk M, Pazdrowski J, Majchrzak E, Barczak
W, Golusinski W, et al: Blood serum from head and neck squamous
cell carcinoma patients induces altered microRNA and target gene
expression profile in treated cells. Front Oncol. 8:2172018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao L, Yang S, You X, He W and Xue J:
Novel miRNA-based biomarker panel for detection β2-agonists in
goats. Food Chem. 288:15–21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Usuba W, Urabe F, Yamamoto Y, Matsuzaki J,
Sasaki H, Ichikawa M, Takizawa S, Aoki Y, Niida S, Kato K, et al:
Circulating miRNA panels for specific and early detection in
bladder cancer. Cancer Sci. 110:408–419. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng D, Ding Y, Ma Q, Zhao L, Guo X, Shen
Y, He Y, Wei W and Liu F: Identification of serum MicroRNAs as
novel biomarkers in esophageal squamous cell carcinoma using
feature selection algorithms. Front Oncol. 8:6742018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen Y, Gong JM, Zhou LL and Sheng JH:
Correction: miR-451 as a new tumor marker for gastric cancer.
Oncotarget. 10:63962019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Li H, Li LH, Tang JB and Sheng YL:
Mir-451 inhibits proliferation and migration of non-small cell lung
cancer cells via targeting LKB1/AMPK. Eur Rev Med Pharmacol Sci. 23
(Suppl 3):S274–S280. 2019.
|
|
20
|
Guo R, Gu J, Zhang Z, Wang Y and Gu C:
miR-451 promotes cell proliferation and metastasis in pancreatic
cancer through targeting CAB39. Biomed Res Int. 2017:23814822017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong W, Feng L, Yang M, Chen Q, Wang H,
Wang X and Hou J: Prognostic value of microRNA-451 in various
cancers: A meta-analysis. Pathol Res Pract. 215:1527262019.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khordadmehr M, Jigari-Asl F, Ezzati H,
Shahbazi R, Sadreddini S, Safaei S and Baradaran B: A comprehensive
review on miR-451: A promising cancer biomarker with therapeutic
potential. J Cell Physiol. 234:21716–21731. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai H and Wu S: miR-451: A novel biomarker
and potential therapeutic target for cancer. Onco Targets Ther.
12:11069–11082. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mamoori A, Wahab R, Vider J, Gopalan V and
Lam AK: The tumour suppressor effects and regulation of cancer stem
cells by macrophage migration inhibitory factor targeted miR-451 in
colon cancer. Gene. 697:165–174. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mamoori A, Gopalan V, Lu CT, Chua TC,
Morris DL, Smith RA and Lam AK: Expression pattern of miR-451 and
its target MIF (macrophage migration inhibitory factor) in
colorectal cancer. J Clin Pathol. 70:308–312. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fan X and Zhao Y: miR-451a inhibits cancer
growth, epithelial-mesenchymal transition and induces apoptosis in
papillary thyroid cancer by targeting PSMB8. J Cell Mol Med.
23:8067–8075. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu D, Fang C, He W, Wu C, Li X and Wu J:
MicroRNA-181a inhibits activated B-cell-like diffuse large B-cell
lymphoma progression by repressing CARD11. J Oncol.
2019:98329562019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu G, Cheng Z, Huang Y, Zheng W, Yang S,
Lin C and Ye J: MyD88 mediates colorectal cancer cell
proliferation, migration and invasion via NF-κB/AP-1 signaling
pathway. Int J Mol Med. 45:131–140. 2020.PubMed/NCBI
|
|
30
|
Yamadera M, Shinto E, Kajiwara Y,
Mochizuki S, Okamoto K, Shimazaki H, Hase K and Ueno H:
Differential clinical impacts of tumour budding evaluated by the
use of immunohistochemical and haematoxylin and eosin staining in
stage II colorectal cancer. Histopathology. 74:1005–1013. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mármol I, Sánchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18:1972017. View Article : Google Scholar
|
|
33
|
To KK, Tong CW, Wu M and Cho WC: MicroRNAs
in the prognosis and therapy of colorectal cancer: From bench to
bedside. World J Gastroenterol. 24:2949–2973. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yalcin S, Trad D, Kader YA, Halawani H,
Demir OG, Mall R, Meshcheryakov A, Nasr F, Nosworthy A, Osinsky D,
et al: Personalized treatment is better than one treatment fits all
in the management of patients with mCRC: A consensus statement.
Future Oncol. 10:2643–2657. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Sun XF, Cao Y, Ye B, Peng Q, Liu
X, Shen B and Zhang H: CBD: A biomarker database for colorectal
cancer. Database (Oxford). 2018:bay0462018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Altuvia Y, Landgraf P, Lithwick G, Elefant
N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H:
Clustering and conservation patterns of human microRNAs. Nucleic
Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu P, Palmer LE, Lechauve C, Zhao G, Yao
Y, Luan J, Vourekas A, Tan H, Peng J, Schuetz JD, et al: Regulation
of gene expression by miR-144/451 during mouse erythropoiesis.
Blood. 133:2518–2528. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shokri G, Kouhkan F, Nojehdehi S,
Soleimani M, Pourfathollah AA, Nikougoftar Zarif M, Tamaddon M and
Obeidi N: Simultaneous regulation of miR-451 and miR-191 led to
erythroid fate decision of mouse embryonic stem cell. Iran J Basic
Med Sci. 224:432–438. 2019.PubMed/NCBI
|
|
39
|
Yao H, Ma Y and Huang LJ: Deletion of
miR-451 curbs JAK2(V617F)-induced erythrocytosis in polycythemia
vera by oxidative stress-mediated erythroblast apoptosis and
hemolysis. Haematologica. 105:e153–e156. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li X, Zhang W, Fu J, Xu Y, Gu R, Qu R, Li
L, Sun Y and Sun X: MicroRNA-451 is downregulated in the follicular
fluid of women with endometriosis and influences mouse and human
embryonic potential. Reprod Biol Endocrinol. 17:962019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang Z, Chang H, Li Y, Zhang T, Zou J,
Zheng X and Wu J: MicroRNAs: Potential regulators involved in human
anencephaly. Int J Biochem Cell Biol. 42:367–374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gan M, Zheng T, Shen L, Tan Y, Fan Y,
Shuai S, Bai L, Li X, Wang J, Zhang S and Zhu L: Genistein reverses
isoproterenol-induced cardiac hypertrophy by regulating
miR-451/TIMP2. Biomed Pharmacother. 112:1086182019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fu C, Chen S, Cai N, Liu Z, Wang P and
Zhao J: Potential neuroprotective effect of miR-451 against
cerebral ischemia/reperfusion injury in stroke patients and a mouse
model. World Neurosurg. 130:e54–e61. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ogawa D, Ansari K, Nowicki MO, Salińska E,
Bronisz A and Godlewski J: MicroRNA-451 inhibits migration of
glioblastoma while making it more susceptible to conventional
therapy. Noncoding RNA. 5:252019.PubMed/NCBI
|
|
45
|
Vidal DO, Ramão A, Pinheiro DG, Muys BR,
Lorenzi JCC, de Pádua Alves C, Zanette DL, de Molfetta GA, Duarte G
and Silva WA Jr: Highly expressed placental miRNAs control key
biological processes in human cancer cell lines. Oncotarget.
9:23554–23563. 2018. View Article : Google Scholar : PubMed/NCBI
|
